Quinz advised Ampersand Capital Partners on its acquisition of Purna Pharmaceuticals from the Van Gucht family and Creafund.
Purna Pharmaceuticals is a trusted partner in liquid and semi-solid pharmaceutical development and manufacturing. This investment creates a compelling opportunity for collaboration with Ampersand portfolio company MedPharm, establishing a trans-Atlantic platform to better serve global pharmaceutical clients with complementary formulation, development, and manufacturing capabilities.
Congratulations to all parties involved!
Quinz deal team: Willem Witters, Sayanah Staelens, Caroline Michiels, Aisha Jaspers
Website
